Interventions Improve Poor Adherence with Once Daily Glaucoma Medications in Electronically Monitored Patients

被引:127
作者
Okeke, Constance O. [1 ]
Quigley, Harry A. [2 ]
Jampel, Henry D. [2 ]
Ying, Gui-shuang [1 ]
Plyler, Ryan J. [2 ]
Jiang, Yuzhen [4 ]
Friedman, David S. [2 ,3 ]
机构
[1] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Sch Med, Philadelphia, PA 19104 USA
[2] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[4] Sun Yat Sen Univ, Dept Prevent Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China
基金
美国国家卫生研究院;
关键词
PHYSICIAN RELATIONSHIPS; TRIAL; BARRIERS; INTERVIEWS; AMERICANS; PRESSURE; CARE;
D O I
10.1016/j.ophtha.2009.05.026
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the impact of an intervention program to improve adherence with topical, once daily therapy for glaucoma. Design: Randomized controlled clinical trial. Participants: Sixty-six patients with glaucoma being treated with a prostaglandin analog in 1 or both eyes at the Scheie Eye Institute or Wilmer Eye Institute between November 2006 and June 2007. Methods: In an observational study, participants who took 75% or fewer doses (as measured using the travoprost Dosing Aid [DA]) during an initial 3-month period were randomized into 2 groups. The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices. The control group was told to take drops as prescribed and received no additional intervention. Main Outcome Measures: Change in drop use adherence as determined by the DA device. Results: In the 3-month observation period before randomization, intervention group patients had used a mean of 54 +/- 17% of scheduled doses, and this increased to 73 +/- 22% during the following 3-month period (P<0.001, n = 35). The control mean adherence rate of 46 +/- 23% at baseline was statistically unchanged during the follow-up observation period (51 +/- 30%, P = 0.16, n = 31). In a multivariate analysis, intervention, baseline compliance rate of <50%, and white ethnicity were predictors of improved adherence during the 3 months of intervention. The intraocular pressure (IOP) of the intervention and control groups did not change between months 3 and 6 after intervention (P = 0.96, 0.34, respectively), and there was no correlation of IOP change with adherence rate change between both groups (Pearson correlation r = 0.06, P = 0.51). Conclusions: A multifaceted intervention significantly increased adherence with glaucoma medications. Those with improved adherence were in the intervention group, had very low adherence rates at baseline, and were white. IOP did not correlate with adherence. Further research is needed to determine which components of this intervention were most effective.
引用
收藏
页码:2286 / 2293
页数:8
相关论文
共 26 条
[1]  
[Anonymous], PATIENT COMPLIANCE M
[2]   Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires [J].
Bender, BG ;
Bender, SE .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2005, 25 (01) :107-+
[3]   Perceived discrimination and adherence to medical care in a racially integrated community [J].
Casagrande, Sarah Stark ;
Gary, Tiffany L. ;
LaVeist, Thomas A. ;
Gaskin, Darrell J. ;
Cooper, Liso A. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (03) :389-395
[4]   Comparison of an SMS text messaging and phone reminder to improve attendance at a health promotion center: A randomized controlled trial [J].
Chen, Zhou-wen ;
Fang, Li-zheng ;
Chen, Li-ying ;
Dai, Hong-lei .
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2008, 9 (01) :34-38
[5]  
Downer Sean R, 2006, Aust Health Rev, V30, P389
[6]   Doctor-patient communication, health-related beliefs, and adherence in glaucoma [J].
Friedman, David S. ;
Hahn, Steven R. ;
Gelb, Laurie ;
Tan, Jason ;
Shah, Sonali N. ;
Kim, Elizabeth E. ;
Zimmerman, Thom J. ;
Quigley, Harry A. .
OPHTHALMOLOGY, 2008, 115 (08) :1320-1327
[7]   The TRAVATAN dosing aid accurately records when drops are taken [J].
Friedman, David S. ;
Jampel, Henry D. ;
Congdon, Nathan G. ;
Miller, Rhonda ;
Quigley, Harry A. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :699-701
[8]  
Haynes RB, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000011.pub3, 10.1002/14651858.CD000011.pub4]
[9]   COMPLIANCE WITH TOPICAL PILOCARPINE TREATMENT [J].
KASS, MA ;
MELTZER, DW ;
GORDON, M ;
COOPER, D ;
GOLDBERG, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (05) :515-523
[10]   CAN OPHTHALMOLOGISTS CORRECTLY IDENTIFY PATIENTS DEFAULTING FROM PILOCARPINE THERAPY [J].
KASS, MA ;
GORDON, M ;
MELTZER, DW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (05) :524-530